Vanguard Portfolio Management’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Buy
92,885
+12,024
+15% +$200K ﹤0.01% 2762
2026
Q2
$1.9M Buy
80,861
+21,950
+37% +$534K ﹤0.01% 2751
2026
Q1
$1.42M Buy
+58,911
New +$1.54M ﹤0.01% 2689

Other funds holding GLSI

Vanguard Portfolio Management's GLSI Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Greenwich LifeSciences (GLSI) stake by 15% in Q3 2026, buying an estimated $200K and bringing the position to 92,885 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Vanguard Portfolio Management first reported a position in GLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.9M in Q2 2026. 42 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • Vanguard Portfolio Management held 92,885 shares of Greenwich LifeSciences worth $1.68M as of Q3 2026.
  • Vanguard Portfolio Management bought 12,024 Greenwich LifeSciences shares in Q3 2026, an estimated $200K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2762 holding.
  • Vanguard Portfolio Management first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Greenwich LifeSciences position peaked at $1.9M in Q2 2026.
  • 42 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.